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Chapter 6  
 Antimicrobial silver-containing 
calcium phosphate coatings* 
Summary 
The aim of this research reported here was to develop a silver-containing 
calcium phosphate (Ag/Ca-P) coating via electrochemical deposition. Two different 
deposition approaches were explored: one-step Ag/Ca-P(1) coatings, containing 
silver ions as micro-sized silver phosphate particles; and via a two-step method 
(Ag/Ca-P(2)) where silver was deposited as metallic silver nanoparticle on the Ca-P 
coating. The Ag/Ca-P(1) coating displays bacterial reduction of 76.1  8.3% via Ag-
ion leaching. The Ag/Ca-P(2) coating displays a bacterial reduction of 83.7  4.5% 
via contact killing. Interestingly, by pre-incubation in phosphate-buffered saline 
solution, bacterial reduction improves to 97.6  2.7% and 99.7  0.4% for Ag/Ca-P(1) 
and Ag/Ca-P(2) coatings, respectively, due to leaching of formed AgClx(x-1)- species. 
The biocompatibility evaluation indicated that the Ag/Ca-P(1) coating is cytotoxic 
towards osteoblasts while the Ag/Ca-P(2) coating shows excellent compatibility. 
 
                                                             
* T. Mokabber, H. T. Cao, N. Norouzi, P. van Rijn, Y.T. Pei, Antimicrobial electrodeposited 






The function of a biomedical implant inside the human body is determined by 
its physical performance as well as the biological interaction. It is well-known that 
chemical, physical and mechanical properties of the implant for a large part dictate 
the interaction with the human body in terms of biocompatibility and bioactivity [1–
3]. However, in addition to the interaction with tissue cells, also interaction with 
other cells such as bacteria is often encountered giving rise to a biomaterial (implant) 
associated infection [4,5]. Therefore, the next generation of metallic implants not 
only need to fulfil the biocompatibility and bioactivity, but also need to prevent 
infection [6–8]. As discussed previously, a smooth layer of calcium phosphate 
coating on titanium surface via electrochemical deposition influences the cell 
adhesion and viability, and subsequently implant biocompatibility [9]. However, 
calcium phosphate coatings are susceptible to bacterial infections caused by the 
adhesion and colonization of bacteria on the implant surface. Biomaterial-associated 
infections, particularly in bone due to hampered vascularization, are difficult to treat 
because the bacteria establish mature biofilms and develop resistance to antibiotic 
treatments [10–12]. Therefore, for an infected implant, the removal and replacement 
is often needed and inflicts substantial burden on the patient [13,14]. 
In order to prevent the initial implant-associated infection, several surface 
antimicrobial strategies have been proposed [15,16]. One of these approaches is 
silver-containing hydroxyapatite coating to provide antimicrobial activity while 
maintaining the bioactivity of the implant. Silver is a well-known antimicrobial agent 
and effective against a broad spectrum of bacterial strains (more than 650 pathogens) 
while being relatively low toxic to mammalian cells. Ag-ions, compounds, and 
nanoparticles are increasingly used for infection treatment due to their excellent 
antimicrobial properties. Regarding the antimicrobial properties, the results of 
previous studies are promising because silver-containing hydroxyapatite structures 
improve the bactericide effect [17–20]. Shi et al. [17] prepared silver-doped 
hydroxyapatite nanocrystals using the hydrothermal method with the silver 
concentration of 0.04 - 197 ppm, which revealed 97% bacteria reduction for the 
highest silver concentration. Xie et al. [19] electrochemically deposited 
hydroxyapatite coatings containing silver nanoparticles, which were supported using 
a Ag-ion coordinating polymer chitosan, exhibited high antimicrobial properties 
against S. epidermidis and E. coli. The mechanism was shown to be a releasing 
system and a dual function of chitosan and silver led to a 94% killing efficiency. 
The comparative role of silver nanoparticles (AgNPs) and silver ions (Ag+) in 
the antimicrobial activity and toxicity against mammalian cells is still a matter of 
discussion [12,21,22]. Moreover, the antimicrobial mechanism of silver-containing 
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materials is not fully understood yet. Contact killing and leaching killing are two 
mechanisms that have been proposed. Bacteria may be killed by direct contact with 
metallic AgNPs, which can attach to the cell wall of the bacteria, form pits in the cell 
membrane, penetrate the cytoplasm and eventually cause cell death [23–25]. 
Another possibility is the gradual release of Ag+ ions from silver-containing material, 
followed by their interaction with thiol groups in proteins, inhibition on cell 
respiration and DNA replication [14,17]. On the other hand, Cao et al. [26] have 
reported that the antimicrobial activity of AgNPs is the result of micro-galvanic effect 
between the AgNPs and Ti matrix and independent of the toxicity of silver ions. 
Therefore, there is remarkable variation in the observed antimicrobial mechanism 
of silver-containing materials. The relationship between the antimicrobial activity 
and the type of the silver in the silver-containing materials is not clearly understood. 
Hence, it is crucial to characterize the chemical composition of the materials 
thoroughly and identify the coating behavior under appropriate working conditions 
in order to elucidate why the coating is a success. Determining the role of silver type 
in the antimicrobial properties and biocompatibility of silver-containing coatings 
has an outstanding importance, which can provide a great opportunity to improve 
the bactericidal coatings for future biomedical implants. 
The aim of the research reported in this chapter was to synthesize silver-
containing calcium phosphate coatings that display high antimicrobial effectiveness. 
Two approaches were used, ionic silver and silver nanoparticle containing coatings 
to identify their role in the antimicrobial properties and the biocompatibility. In 
order to deposit silver-containing calcium phosphate coatings, either with silver ions 
or silver nanoparticles, the electrochemical deposition was applied, which allows the 
formation of a uniform coating on highly irregularly shaped objects [27]. The 
chemical composition and microstructure of the coatings were characterized. 
Furthermore, Staphylococcus aureus and osteosarcoma cells (SaOs) were used to 
evaluate the antimicrobial properties and biocompatibility of the coatings, 
respectively. The influence of pre-incubation in different solutions on the 
antimicrobial properties of the coatings was studied and the overall antimicrobial 
mechanism of the coatings investigated.  
6.2 Materials and methods 
6.2.1 Synthesis and characterization of Ag/Ca-P coatings 
The Ag/Ca-P coating containing ionic silver was deposited via electrochemical 
deposition on Ti substrates through one-step, and is depicted as Ag/Ca-P(1). The 
details of deposition and substrate preparation were reported in the previous 




0.025 M NH4H2PO4 (Alfa Aeser), 10 mM AgNO3 (Sigma-Aldrich), and 1.5 wt.% of 
H2O2 was prepared in distilled water. Pulsed electrodeposition was conducted in a 
regular two-electrode cell and carried out with fixed frequency (1.0 Hz) at a voltage 
of -1.4 V and temperature of 65  1 C. The deposition of Ag/Ca-P coating containing 
AgNPs was conducted through two separate steps: first Ca-P coating was deposited 
on Ti substrate for 1 min. In the second step, AgNPs were deposited onto the Ca-P 
coating which is discussed in more details in [28]. The deposition of AgNPs was also 
conducted in a conventional two-electrode cell in which the Ca-P coating was used 
as the cathode, and a platinum sheet was used as the anode. The electrolyte solution, 
which contains 1.25 mM NaCl (Merck), was heated to 95  1 C. Afterwards, 1.25 mM 
AgNO3 (Sigma-Aldrich) was added to the electrolyte under stirring. Electrochemical 
deposition of AgNPs was conducted at a constant voltage of −1.4 V for 6 min, and 
Ag+ was reduced to Ag0 at the surface of the Ca-P coating. The coating deposited in 
two steps is depicted as Ag/Ca-P(2). 
The phase composition of the coatings was studied by X-ray diffraction (XRD, 
Bruker D-8 Advance-Germany Spectrometer), with Cu-Kα radiation of λ=1.5406 Å 
under 40 kV and 40 mA. XRD data were collected in the 2 theta range of 10 to 70 
with a step size of 0.02°. The surface morphology of the coatings was observed by 
using a Philips ESEM-XL30 environmental scanning electron microscope (ESEM). 
The element distribution of the Ag/Ca-P(1) coating was further studied by SEM 
equipped with energy dispersive spectroscopy (SEM/EDS). Before SEM observation, 
the coatings were sputtered with gold. X-ray photoelectron spectroscopy (XPS) was 
employed to investigate the elemental compositions and chemical bonding of the 
Ag/Ca-P(1) coating using a Surface Science SSX-100 ESCA instrument with a 
monochromatic Al Ka X-ray source (hυ = 1486.6 eV). During data acquisition, the 
pressure in the measurement chamber was kept below 2×10-7 Pa. Spectra analysis 
included a Shirley background subtraction and peak separation adopting mixed 
Gaussian-Lorentzian functions in a least-squares curve fitting program (Winspec, 
developed at the LISE laboratory of the Faculte’s Universitaires Notre-Dame de la 
Paix, Namur, Belgium). The microstructure of the Ag/Ca-P(2) coating was revealed 
by transmission electron microscope (TEM, JEOL 2010F, 200 kV). 
6.2.2 Silver ion release 
The study of silver ion release was carried out by immersing the substrate 
bearing the Ag/Ca-P coating in 10 mL PBS solution and incubating at 37 °C with a 
shaking speed of 50 rpm in the dark. The release rate was determined by extracting 
1 mL Ag released solution after 6, 12, 24, 48, and 72 h and analyzed by inductively 
coupled plasma optical emission spectrometer (ICP-OES) OPTIMA 7000 DV (Perkin 
Elmer). The same volume of fresh PBS was added to the samples to keep a constant 
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incubation volume. Experiments for all conditions were separately analyzed in 
triplicate. 
6.2.3 Bacteria strain and growth condition 
Gram-positive Staphylococcus aureus (S. aureus ATCC 12600) was used in this 
study. The bacteria strain was first grown overnight at 37 °C on a blood agar plate 
from a frozen stock solution (DMSO). One colony was inoculated in 10 mL tryptone 
soya broth (TSB; Oxoid, Basingstoke, UK) and incubated at 37 °C for 24 h.  This pre-
culture was used to inoculate a main culture of 200 mL TSB that was allowed to grow 
for 16 h at 37 °C. The bacteria from the main culture were harvested by centrifugation 
at 6500g for 5 min at 10 °C three times and washed with PBS solution. Subsequently, 
bacteria were sonicated on ice at 30 W for 30 s (Vibra Cell model VCX130; Sonics 
and Materials Inc., Newtown, CT, USA) to break down the bacteria clusters. 
Afterwards, the number of bacteria in suspension was determined by Bürker-Türk 
counting chamber, and the concentration was adjusted to 1.0 × 105 CFU/ml (colony 
forming units) for further experiments. 
6.2.4 Colony count method  
Colony count method is an appropriate way to quantitatively evaluate the 
bacteria-colony reduction on the coatings. All the laboratory supplies, as well as the 
coatings, were sterilized at 121 °C for 20 min by autoclave. Before introducing the 
bacteria suspension, the coatings were pre-treated by PBS, ultra-pure water, and 
culture medium without bacteria. In order to pre-treated the coatings by mentioned 
solutions, the coatings were immersed in 500 µl of the solution inside 24-well plates, 
and incubated at 37 °C with a shaking speed of 50 rpm in the dark for 48 h. 
Subsequently, the solutions were extracted, and 1 ml of bacteria suspension with an 
initial concentration of 1.0 × 105 CFU/ml was introduced onto the coatings, both 
treated and non-treated, and followed by incubation at 37 °C for 24 h. After 
incubation, the coatings were rinsed with PBS to remove the poorly attached bacteria. 
In order to detach the biofilm formed on the coatings, the coatings were sonicated 
using an ultrasonic bath for 5 min in 1 ml PBS. For subsequent bacterial counting, 
the detached bacteria suspension was serially diluted in ten-fold steps with PBS. The 
diluted suspension was spread over a TSB agar plate and incubated at 37 °C 
overnight; the active bacteria were counted and used to calculate the bacteria 








where    is the number of bacteria on the pure Ca-P coating as the control and    is 
the number of bacteria on the Ag/Ca-P coatings. All the experiments are performed 
in triplicate. 
6.2.5 Live/dead staining 
To study the initial bacterial adhesion, bacteria which were seeded on the 
coatings for 4, 6, and 24 h were stained with a Live/dead BacLight kit (Invitrogen, 
USA). After each time point, the culture medium was removed, and the samples were 
rinsed with PBS. The live/dead staining solution was prepared by mixing 
components A (SYTO 9) and B (propidium Iodide) with 1:1 ratio and added to the 
PBS solution. After adding 250 µl of staining solution to each well plate, samples 
were incubated for 15 min at room temperature in the dark. The cells were imaged 
by fluorescence microscopy (Leica DFC350 FX). 
6.2.6 Biocompatibility   
Osteosarcoma cells (SaOs), a human osteoblast cell line, with a concentration 
of 4.0104 cells/ml, were used to evaluate the biocompatibility of Ag/Ca-P coatings. 
In order to study the biocompatibility of the coatings, XTT assay, live/dead staining 
test and SEM observation were used according the protocol described in pervious 
chapter. 
6.2.7 Statistical analysis 
All data points were expressed as mean values ± standard deviations with n = 3. 
Statistical analysis was performed using Origin 8.0 software through one-way 
ANOVA, followed by Tukey's test. Statistical significance was considered at a value 
of p < 0.05. 
6.3 Results and discussion 
6.3.1 Characterization of Ag/Ca-P coatings 
The XRD patterns of the Ca-P and the Ag/Ca-P coatings after depositing on 
titanium substrates are illustrated in Figure 6-1. As it is expected, the XRD pattern 
of the Ca-P coating shows the typical peaks of hydroxyapatite, octa-calcium 
phosphate, and titanium [29]. The XRD pattern of the Ag/Ca-P(2) coating shows the 
same peaks as well as the diffraction peaks of pure silver. The main peak of metallic 
silver at 2 theta value of 38.1 has an overlap with the diffraction peak of titanium at 
2 theta value of 38.5. However, the diffraction peaks at 2 theta values of 44.3 and 
64.4 are corresponding to metallic silver (JCPDS No. 04-0783). In the XRD pattern 
of the Ag/Ca-P(1) coating no diffraction peak related to metallic silver is observed, 
but well-distinguished diffraction peaks of silver phosphate (Ag3PO4) at 2 theta 
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values of 20.9, 29.7, 33.4 and 36.8 can be seen (JCPDS No. 06-0505). For Ag3PO4 
of body centered cubic structure, the XRD peak intensity ratio of (200) to (110) 
planes, which correspond to the peaks at 2 theta values of 29.7 and 20.9, is 1.29. In 
the XRD pattern of Ag/Ca-P(1) coating, this ratio is 0.83 indicating that the structure 
of deposited Ag3PO4 crystals in the Ag/Ca-P(1) coating is primarily composed of {110} 
crystal facets. As a result, the crystallographic structure of Ag3PO4 crystals in the 
Ag/Ca-P(1) coating is rhombic dodecahedral [30,31].  
 
Figure 6-1 X-ray diffraction patterns of Ca-P and Ag/Ca-P coatings. 
The surface morphology and the element distribution of the Ag/Ca-P(1) coating 
was observed by SEM and EDS. The SEM observation reveals that the morphology 
of the Ag/Ca-P(1) coating consists of micro-sized particles embedded in a flat and 
smooth layer (Figure 6-2a). The high magnification SEM images in Figure 6-2b and 
2c show that the particles are rhombic dodecahedral crystals consisting of 12 well-
defined crystal faces which are enclosed by {110} facets [30,32]. According to the 
EDS elemental analysis in Figure 6-2d-h, the deposited background layer is a 
calcium phosphate layer because of the existence of calcium, phosphor and oxygen 
ions. Meanwhile, the presence of silver and phosphor ions and the absence of 
calcium ions in the particles demonstrate that the embedded particles are Ag3PO4 
crystals. These findings agree well with the XRD results. 



































































Figure 6-2 (a-c) SEM micrograph at different magnifications showing the size distribution 
and morphology of Ag3PO4 particles in the Ag/Ca-P(1) coating, (d-h) EDS elemental 
mappings corresponding to the SEM micrograph in (b). 
Furthermore, XPS spectroscopy was used to determine the surface composition 
and the chemical state of the silver in the Ag/Ca-P(1) coating. Figure 6-3 illustrates 
the XPS wide scan spectra conducted on the surface of Ag/Ca-P(1) coating and also 
the XPS high resolution scan of the Ag 3d core level region. The presence of C 1s peak 
is attributed to the adsorption of adventitious hydrocarbons. This peak is used for 
calibrating the binding energy (BE) to correct sample charging (BE of C 1s = 284.8 
eV) [33]. In the XPS wide scan spectra (Figure 6-3a), the peaks corresponding to Ca 
2p, P 2p, O 1s and Ag 3d are distinct and in good agreement with those reported in 
literature [34,35]. The XPS high-resolution spectrum of the Ag 3d core region is 
shown in Figure 6-3b. As it is seen, the Ag 3d spectrum consists of two individual 
peaks which can be attributed to Ag (3d5/2) at BE of 367.8 eV and Ag (3d3/2) at BE of 
373.7 eV, respectively, and the splitting of the 3d doublet is 5.9 eV. The Ag 3d high 
resolution spectrum can be further deconvoluted in three different doubles 
originating from metallic (Ag, 368.6 eV) and oxide states (Ag2O, 368.2 eV and AgO, 
367.8 eV) [36]. The deconvolution analysis demonstrates that about 38% and 50% 
of the silver is respectively Ag+ and Ag2+; while, about 12% of the silver is Ag0. 
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Consequently, most of the silver in the Ag/Ca-P(1) coating is in the ionic state rather 
than the metallic state. The XPS results provide additional evidence for the 
formation of Ag3PO4 in the Ag/Ca-P(1) coating. 
           
Figure 6-3 (a) XPS survey spectra of the Ag/Ca-P(1) coating and (b) high resolution scan of 
Ag 3d spectra. 
By the combination of XRD, EDS and XPS analyses, it can be concluded that in 
the electrochemical deposition process of the Ag/Ca-P(1) coating, Ag+ ions prefer to 
react with PO43+ ions and form Ag3PO4 particles rather than to dope inside the 
structure of Ca-P crystals. This finding is in contrast with the previous studies which 
reported that silver ions could be doped inside the structure of the Ca-P crystals 
during the electrodeposition process [37]. During the electrodeposition of the 
Ag/Ca-P(1) coating, silver ions have stronger tendency to react with PO43+ ions rather 
than to replace the Ca ions. This can be attributed to the larger ionic radius of silver 
compared to calcium (rAg+ = 1.28 Å and rCa2+ = 0.99 Å) and also to the higher reaction 
intensity of phosphate ions with silver [38,39]. Rameshbabu et al. synthesized silver-
substituted nanosized hydroxyapatite (Ca10-xAgx(PO4)6(OH)2) via microwave 
processing [38]. They reported that in higher concentration of silver (x > 0.4) the 
silver phosphate crystals formed. They claimed that the silver ions size effect, 
polarizability, charge, chemical nature of silver, and crystal size of the HA might 
reduce the substitution of calcium ions by silver ions. 
The microstructure of the Ag/Ca-P(2) coating was examined by SEM and TEM 
(Figure 6-4). As it is seen in Figure 6-4a, the Ag/Ca-P(2) coating has similar 
morphology to the Ca-P coating synthesized in 1 minutes (Figure 4-1a). The surface 
morphology of Ag/Ca-P(2) coating is smooth with low roughness, which was 
previously found to be beneficial for osteoblast adhesion and viability [9]. The 
bright-field TEM images of the Ag/Ca-P(2) coating in Figure 6-4b and c show the 
nanoplates of Ca-P and the attachment of silver nanoparticles with uniform 
distribution on the Ca-P plates without any agglomeration. The homogeneous 











































































distribution of the silver nanoparticles is a critical parameter in determining the 
successful application of the nanoparticles [40]. The EDS spectra confirm that 
attached particles are silver, which is in agreement with the XRD results. The Ag/Ca-
P(2) coating is further investigated using HRTEM (Figure 6-4d-f). Figure 6-4d 
displays the lattice fringes of both Ca-P plates and silver nanoparticles. The inter-
planar spacing is estimated to be 0.35 and 0.24 nm for the Ca-P and silver, 
respectively, which is identified as (002) planes of HA and (111) planes of silver 
(d002,HA = 0.344 nm and d111,Ag = 0.236 nm). According to the TEM and HRTEM 
observations, the diameter of the silver nanoparticles ranges between 3 - 7 nm. In 
summary, during the deposition of the Ag/Ca-P(2) coating in the second step, 
through the cathodic reaction, the silver ions reduce to metallic silver and deposit as 
silver nanoparticles on the Ca-P coating. 
 
Figure 6-4 (a) SEM micrograph, (b-c) TEM micrographs, and (d-f) HRTEM micrographs of 
the Ag/Ca-P(2) coating. 
6.3.2 Silver release of Ag/Ca-P coatings 
Figure 6-5 shows the silver ions release profile from Ag/Ca-P coatings as a 
function of time in PBS solution. Initially, a fast release of Ag+ appears from the 
Ag/Ca-P(1) coating in the first 12 h of immersion, which can prevent the initial 
bacterial adhesion and biofilm formation [41]. After 12 h, the Ag+ release rate from 
Ag/Ca-P(1) coating gradually slows down and reaches a near steady-state with the 
maximum released silver of 173.5  23 ppb. The amount of released silver in PBS 
from the Ag/Ca-P(1) coating is determined to be more than the amount released 
from the Ag/Ca-P(2) coating before 48 h. For the Ag/Ca-P(2) coating, the silver 
release is not detected at the first 12 h, and after 24 h only 37.3  45 ppb silver ions 
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are released. The maximum concentration of the silver released from the Ag/Ca-P(2) 
coating is 220.7  45 ppb after 48 h. The difference in the releasing behavior of the 
silver from the Ag/Ca-P coatings can be explained by the differences in the silver 
species [42]. The Ag/Ca-P(1) coating contains micro-sized silver phosphate particles, 
whereas silver is deposited on the Ag/Ca-P(2) coating as silver nanoparticles. The 
dissolution rate of a silver component in aqueous solutions is higher than that of 
metallic silver [43], resulting in different silver release rate from the two Ag/Ca-P 
coatings. 
 
Figure 6-5. Silver ions release profile from Ag/Ca-P coatings as a function of time in PBS 
solution. *P ≤0.05. 
6.3.3 Antimicrobial evaluation of Ag/Ca-P coatings 
The antimicrobial mechanism can be due to one of the following reasons: (1) 
direct contact with antimicrobial material (in this case Ag3PO4 or AgNPs) and (2) 
interaction with silver ions released from antimicrobial material. Since the silver 
release rate of the Ag/Ca-P coatings is a function of time, to evaluate the 
antimicrobial properties of the Ag/Ca-P coatings, a series of experiments were 
designed as pre-treatments prior to bacteria incubation and the antimicrobial 
properties were evaluated via colony count method and Live/dead staining test. The 
pre-treatments included the immersion of the coatings inside PBS, ultra-pure water, 
and culture medium for 48 h. S. aureus with the initial concentration of 1.0 × 105 
CFU/ml were added on the coatings either directly or after the pre-treatment. The 
results are shown as bacterial reduction percentage compared to the control (Figure 
6-6a) and number of CFUs (Figure 6-6b). As shown in Figure 6-6a, when the bacteria 
are directly added on the coatings, without any pre-treatment, the number of S. 


































aureus decreases by 76.1  8.3 and 83.7  4.5% for the Ag/Ca-P(1) and Ag/Ca-P(2) 
coatings, respectively. However, the antimicrobial activity improves to 97.6  2 and 
99.7  0.4% for the Ag/Ca-P(1) and Ag/Ca-P(2) coatings, respectively, which have 
been pre-treated in PBS solution for 48 h. Pre-treating the coatings in ultra-pure 
water does not change the bacteria reduction percentage compared to the coatings 
without the pre-treatment. However, immersing the coatings in the culture medium 
significantly suppresses the antimicrobial activity, to which may be due 
sedimentation of proteins existing in the culture medium and thereby covering the 
surface of the coatings. The differences in coating effectiveness due to the different 
treatments indicates that the effectiveness may be drastically enhanced or 
suppressed by the experimental setup and it emphasizes to all factors carefully need 
to be considered. Figure 6-6b illustrates that the number of CFUs on the Ag/Ca-P 
coatings is significantly lower than that of on the Ca-P coating as the control for all 
groups of the coatings except the coatings treated in the culture medium.  
         
Figure 6-6 (a) The percentage of bacteria reduction against S. aureus and (b) number of 
CFUs after 24 h incubation on the Ca-P and Ag/Ca-P coatings with and without pre-
treatment in different media. *P ≤0.05, **P ≤0.005 and ***P ≤0.001. 
Considering the planktonic bacteria, almost the same trend is observed for the 
bacterial reduction percentage and the number of CFUs. Figure 6-7a and b show 
bacterial reduction percentage compared to the control and the number of CFUs 
within planktonic suspension, respectively. The planktonic bacteria reduction 
corresponding to the coatings pre-treated by PBS is significantly higher comparing 
to the non-treated coatings.  In conclusion, although the coatings without any pre-
treatment possess outstanding antimicrobial activities, the pre-treatment in PBS for 
48 h remarkably improves the antimicrobial activity of the coatings, which is a 
procedure that is easily implemented into clinical settings and enhances the usability 
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Figure 6-7 (a) The percentage of bacteria reduction against S. aureus and (b) number of 
CFUs within planktonic suspension after 24 h incubation on the Ca-P and Ag/Ca-P coatings 
with and without pre-treatment in different media. *P ≤0.05, **P ≤0.005 and ***P ≤0.001. 
Representative fluorescence images of S. aureus on the Ca-P and Ag/Ca-P 
coatings without any pre-treatment and coatings pre-treated by PBS are shown in 
Figure 6-8. Figure 6-8b1 and b2 indicates that there is a minimal number of alive 
bacteria in the first 6 h of incubation on the Ag/Ca-P(1) coating without the pre-
treatment. The absence of dead bacteria on the Ag/Ca-P(1) coating in the first 6 h of 
incubation can be attributed to the high release rate of silver ions from Ag3PO4 
particles (Figure 6-5), which prevents bacteria to adhere to the surface of the coating 
[41]. During the deposition of the Ca-P coatings, one third of the titanium substrate 
is not coated because of the deposition set up (Figure 6-9). This area acts as an 
internal control to elucidate potential killing mechanisms. Figure 6-10 illustrates 
fluorescence micrographs of S. aureus on non-coated section of the Ca-P and Ag/Ca-
P coatings. Interestingly, the number of alive bacteria in the non-coated titanium 
section where the rest contains the Ag/Ca-P(1) coating, is minimal (Figure 6-10b1). 
Based on these results, it can be concluded that the antimicrobial mechanism of 
Ag/Ca-P(1) coating at the first 6 h of incubation is leaching killing as it also affects 
the non-coated area drastically. However, after 24 h of incubation (Figure 6-8b3), 
both live and dead bacteria are visible on the coating surface. Nevertheless, the 
validity of bacteria growing on the Ag/Ca-P(1) coating is much lower than that on the 
control coating (Figure 6-8a3), which is in agreement with CFU counting results in 
Figure 6-6. It seems that the Ag/Ca-P(1) coating loses its antimicrobial activity to 
some degree after 24 h of incubation, which is attributed to the crystallographic 
structure of Ag3PO4 particles. Yeo et al. [30] reported that in the first 8 h of 
incubation, both cubic and rhombic dodecahedral Ag3PO4 have excellent 
antimicrobial activity. However, after 10 h of incubation, E. coli can grow in the 
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surfaces of cubic Ag3PO4 is much higher than that on the {110} surfaces of rhombic 
dodecahedral Ag3PO4. As a result, the increased number of live bacteria after 24 h of 
incubation is attributed to the structure of the deposited rhombic dodecahedral 
Ag3PO4 crystals in the Ag/Ca-P(1) coating.  
 
Figure 6-8 Fluorescence microscopy images of S. aureus on (a) Ca-P coating as control, (b) 
Ag/Ca-P(1) coating and (c) Ag/Ca-P(2) coating after incubation for (a1 – c1) 4 h, (a2 – c2) 6 
h and (a3 – c3) 24 h, and (a4 – c4) after 24 h incubation on the coatings pre-treated by PBS 
solution. Green and red indicate live and dead bacteria, respectively. 
In the case of the non-treated Ag/Ca-P(2) coating, the fluorescence microscopy 
images (Figure 6-8c1 – c3) illustrate that, at all the time points, the number of live 
bacteria on the coating is much lower than that on the control. Additionally, the 
absence of dead bacteria at the first 6 h of incubation on the Ag/Ca-P(2) coating 
suggests that AgNPs mainly prevent bacterial growth through physical contact. 
According to the ICP results, by the first 12 h, silver ion release from the Ag/Ca-P(2) 
coating is minimal. Therefore, we can concluded that the main antimicrobial 
mechanism of the Ag/Ca-P(2) coating is contact killing [25,26]. The considerable 
amount of alive bacteria on non-coated titanium section of the Ag/Ca-P(2) coating 
after 6 h of incubation (Figure 6-10c1) also supports contact killing mechanism. After 
24 h of incubation, the number of alive bacteria on the Ag/Ca-P(2) coating increases 
but still is much lower than on the control coating. Figure 6-8a4 – c4 show the 
bacteria cultured for 24 h on the coatings pre-treated by PBS. On the Ca-P coating, a 
significant number of live bacteria adhere and form a dense biofilm. In contrast, on 
the Ag/Ca-P(1) and Ag/Ca-P(2) coatings, only a small number of alive bacteria are 
observed. Besides, there are just a few alive bacteria on the non-coated titanium 
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section of these coatings (Figure 6-10b2 and c2). In conclusion, the antimicrobial 
mechanism of both Ag/Ca-P(1) and Ag/Ca-P(2) coatings pre-treated by PBS is 
leaching killing. The results of live/dead staining confirm the impressive bacterial 
reduction on the pre-treated Ag/Ca-P coatings concluded from CFU counting. 
 
Figure 6-9 A titanium disc partially coated with Ag/Ca-P coating. 
 
Figure 6-10 Fluorescence microscopy images of S. aureus on non-coated Ti section of 
samples in (a) Ca-P coating as control, (b) Ag/Ca-P(1) coating and (c) Ag/Ca-P(2) coating 
after incubation for (a1 – c1) 6 h and (a2 – c2) 24 h on coatings pre-treated by PBS. Green 




The improvement of antimicrobial activity through immersing the Ag/Ca-P 
coatings inside PBS is associated with the presence of chloride ions in the PBS 
solution. In general, the presence of chloride ions influences the toxicity of silver 
species due to the formation of solid AgCl which has a very low solubility (Ksp = 1.77 
 10-10 mol/l²) [44,45]. However, in higher concentration of chloride, there is a 
possibility of formation of soluble AgClx(x-1)- species, resulting in enhanced 
antimicrobial activity [46]. Levard et al. [47] studied the stability and dissolution 
kinetics of AgNPs in the presence of chloride ions and also its effect on the growth 
inhibition of E. coli. They reported that a low amount of chloride ions in the solution 
remarkably decreases the release rate of AgNPs due to the precipitation of solid AgCl. 
Nevertheless, by increasing the concentration of chloride ions, the solid AgCl 
becomes thermodynamically unstable, and the dominant phase would be soluble 
AgClx(x-1)- species, resulting higher dissolution rate of AgNPs compared to that of in 
DI water control. They also claimed that the toxicity of AgNPs toward E. coli is due 
to the soluble species of Ag rather than the AgNP effect. Consequently, the enhanced 
antimicrobial activity of the pre-treated Ag/Ca-P coatings is attributed to the 
formation of AgClx(x-1)- species and the presence of the chloride in the Ag/Ca-P 
coatings is proved by EDS analysis (Figure 6-11). These results also coincide with the  
 
Figure 6-11 Energy dispersive X-ray analysis spectra of Ag/Ca-P(2) coating after pre-
treatment by PBS solution. 
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release study of silver ions in PBS where after 24 h the release increases indicating 
that this time is needed to form a suitable amount of AgClx(x-1)- species to become 
detectable and active towards bacteria. Similar results were obtained by heat 
treatment of Ag/Ca-P coatings. Zhang et al. [48] reported improvement of the 
antimicrobial activity of Ag/Ca-P coatings through heat treatment.  They found that 
heat treatment in air results in silver oxide formation, which is more susceptible to 
leaching silver ions than the unheated silver nanoparticles. However, considering the 
simplicity of the PBS treatment, immersion in the PBS solution is preferable in order 
to enhance the antimicrobial activity of the coatings. 
A schematic illustration of the proposed antimicrobial mechanism of the Ag/Ca-
P coatings is shown in Figure 6-12. In the case of Ag/Ca-P(1) coating, the high release 
rate of silver ions from Ag3PO4 in the first 6 h of bacteria incubation results in 
leaching killing. After 24 h bacteria incubation, the silver release rate slowly 
decreases, but the antimicrobial mechanism is still the same, and the bacteria 
reduction is 76.1  8.3%. In contrast, in the case of Ag/Ca-P(2) coating, the 
antimicrobial mechanism is mainly contact killing due to the very low amount of 
silver release even after 24 h of incubation, and the bacteria reduction is 83.7  4.5%. 
 




However, if the Ag/Ca-P coatings are pre-treated by PBS, due to the high 
concentration of chloride ions in PBS, soluble AgClx(x-1)- species will form on both 
Ag3PO4 and AgNPs. When the pre-treated coatings are exposed to bacteria solution, 
the high release rate of silver ions from soluble AgClx(x-1)- species causes bacterial 
reduction of 97.6  2.7% and 99.7  0.4% for the Ag/Ca-P(1) and Ag/Ca-P(2) coatings, 
respectively, which is associated to the leaching killing. 
6.3.4 SaOs osteoblast cell response on Ag/Ca-P coatings 
A successfully modified surface should fulfill not only the antimicrobial activity 
against bacteria, but also the cytocompatibility toward the mammalian cells. In order 
to evaluate the biocompatibility of Ag/Ca-P coatings, SaOs cells were cultured for 24 
h on the coatings and their behavior was investigated via XTT assay, live/dead cell 
staining test and SEM observation. Figure 6-13 shows the metabolic activity and the 
number of living cells per unit surface area on the Ag/Ca-P coatings, as well as on 
the Ca-P coating as the control. The metabolic activity of the cells on the Ag/Ca-P(1) 
coating is very low, suggesting that the Ag/Ca-P(1) coating is cytotoxic for SaOs cells 
[49]. Nevertheless, the metabolic activity of cells on the Ag/Ca-P(2) coating and the 
control is very similar. Likewise, the number of live cells on Ag/Ca-P(1) coating is 
almost zero. However, the number of live cells on the Ag/Ca-P(2) and the Ca-P 
coatings are comparable and no significant difference is observed, which is in 
agreement with the XTT assay results and indicates that Ag/Ca-P(2) coating is 
biocompatible while the Ag/Ca-P(1) coating is not.  
 
Figure 6-13 Metabolic activity (XTT assay) and the number of live SaOs cells after 24 h 
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Figure 6-14 shows the fluorescence microscopy and SEM images of SaOs cells 
cultured for 24 h on the Ca-P and Ag/Ca-P(2) coatings. As shown in the fluorescence 
images, almost all of the cells are alive on the control and the Ag/Ca-P(2) coating 
(Figure 6-14a1 and b1). Furthermore, the SEM images illustrate that the SaOs cells 
spread out and attach very well on the coatings with abundant lamellipodia and 
filopodia extensions. The SEM images of an individual cell (Figure 6-14a3 and b3) 
reveal that the morphology of the cell on the Ag/Ca-P(2) coating is comparable with 
that on the control. These findings indicates that the presence of AgNPs in the 
Ag/Ca-P(2) coating does not influence the viability and morphology of the SaOs cell 
and the coating is biocompatible. Earlier studies also have reported that the surfaces 
which were decorated by AgNPs have excellent antimicrobial properties meanwhile 
could support the viability of mammalian cells without cytotoxicity [19,24,50]. 
 
Figure 6-14 (a1 and b1) fluorescence microscopy and (a2-a3 and b2-b3) SEM images of S. 
aureus after incubation for 24 h on (a) Ca-P coating as control, (b) Ag/Ca-P(2) coating. 
Green and red indicate live and dead bacteria, respectively. 
The development of a functional biomedical implant includes surface 
modifications that can accomplish a good interaction with the human body in terms 
of biocompatibility and bioactivity, along with the prevention of implant-associated 
infections. The calcium phosphate coatings containing silver nanoparticles (Ag/Ca-
P(2)) possess all these properties, therefore are promising candidates for modifying 
biomedical implants. Our findings have important indications in evaluating the role 
of silver type in the antimicrobial properties and biocompatibility of silver-





The physico-chemical characteristics of silver in the silver-containing coatings 
are crucial factors influencing antimicrobial activity and cytotoxicity of the coatings. 
In this research, silver-containing calcium phosphate coatings were deposited on 
titanium substrates via electrochemical deposition to study their antimicrobial 
properties and biocompatibility regarding the silver type inside the coatings. Silver 
in the Ag/Ca-P(1) coating has the ionic chemical state, and deposited as micro-sized 
silver phosphate particles embedded inside the Ca-P matrix. Whereas, in the Ag/Ca-
P(2) coating, silver deposited as metallic nanoparticles on the Ca-P coating. The 
antimicrobial evaluation against S. aureus revealed that the high release rate of silver 
ions from the Ag/Ca-P(1) coating results in leaching killing, and the bacteria 
reduction is 76.1  8.3%. The antimicrobial mechanism of the Ag/Ca-P(2) coating is 
mainly contact killing, and the bacteria reduction is 83.7  4.5%. Pretreatment by 
PBS leads to improvement of the bacteria reduction to 97.6  2.7% and 99.7  0.4% 
for Ag/Ca-P(1) and Ag/Ca-P(2) coating, respectively. The enhanced antimicrobial 
activity after PBS treatment can be attributed to the formation of soluble AgClx(x-1)- 
species on the Ag3PO4 and AgNPs, which results in high silver release rate and 
leaching killing. According to the biocompatibility assay, the Ag/Ca-P(1) coating is 
cytotoxic towards the cells. In contrast, the Ag/Ca-P(2) coating shows excellent 
biocompatibility. The results of the current investigation shows that the 
electrochemically deposited Ag/Ca-P coatings containing silver nanoparticles with 
excellent antimicrobial activity accompanied by efficient biocompatibility can be 
applied on titanium, a commonly used material for medical implants. Although, not 
used here, the electrochemical deposition has the advantage of depositing uniformly 
on highly irregular shapes and porous materials. Implants and their design become 
more complex, also due to the available 3-D printing approaches, and hence new 
strategies for applying highly effective antimicrobial coatings with excellent 
biocompatibility will accelerate the development and usability of such novel 
biomedical implants. 
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